Vardenafil Hydrochloride

Vardenafil Hydrochloride

Vardenafil Hydrochloride is a high-purity small-molecule phosphodiesterase type 5 inhibitor synthesized under rigorous compliance frameworks for commercial pharmaceutical formulation development and large-scale solid oral dosage production.

Product Introduction

Vardenafil Hydrochloride is a high-purity small-molecule phosphodiesterase type 5 inhibitor synthesized under rigorous compliance frameworks for commercial pharmaceutical formulation development and large-scale solid oral dosage production.

 

Product Identification & Specifications

 

Parameter

Technical Standard

Analytical Method

CAS Number

224785-90-4

Literature Reference

Molecular Weight

579.11 g/mol

Stoichiometric Calculation

Appearance

White to off-white crystalline powder

Visual Inspection

Assay (Dried Basis)

99.0% to 101.0%

High-Performance Liquid Chromatography

Specified Impurities

Less than or equal to 0.10% (Individual)

Gradient HPLC

Total Impurities

Less than or equal to 0.5% (Aggregate)

Gradient HPLC

Melting Point

215 deg C to 220 deg C

Capillary Melting Point

Particle Size Distribution

D90 under 45 um, D50 under 15 um

Laser Diffraction

 

Chemical & Physical Profile

 

Solubility Parameters: Freely soluble in dimethyl sulfoxide, sparingly soluble in methanol, and exhibits pH-dependent aqueous dissolution behavior optimized for oral bioavailability enhancement.


Moisture Control: Water content strictly maintained below 1.0% via Karl Fischer titration, preventing premature hydrolytic degradation during processing.


Residual Solvents: Class 3 solvents controlled well below ICH Q3C limits, eliminating downstream removal bottlenecks during final drying stages.

 

Technical & Structural Integrity

 

Polymorphic Purity: Synthesized via a validated crystallization route yielding a single thermodynamic crystal form confirmed via X-ray powder diffraction.


Chiral Integrity: Enantiomeric purity verified by chiral chromatography, maintaining optical purity greater than 99.5% to prevent isomeric impurity accumulation.


Elemental Impurities: Quantified via ICP-MS, ensuring all toxic elements remain below 10 ppm per regulatory mandates.

 

Formulation & Processing Considerations

 

Excipient Compatibility: Inert behavior demonstrated with standard tableting excipients including microcrystalline cellulose, lactose monohydrate, and magnesium stearate.


Compression Stability: High mechanical strength under standard compression forces, preventing capping or lamination during high-speed rotary tablet pressing.


Environmental Controls: Requires low-humidity processing environments (relative humidity under 45%) and standard moisture-barrier packaging operations.

 

Typical Applications

 

Oral Solid Dosage: Primary active ingredient for manufacturing film-coated tablets in dosages ranging from 5 mg to 20 mg.


Rapid-Dissolve Formulations: Suitable for orally disintegrating tablets requiring tightly controlled fine particle size distribution.


Combination Therapies: Utilized in research pipelines for multi-active fixed-dose formulations targeting male sexual health indications.

 

Quality Assurance & Control

 

Chromatographic Purity: Assayed via liquid chromatography equipped with ultraviolet detection, validated for linearity, precision, and accuracy.


Microbial Limits: Total aerobic microbial count maintained below 1000 CFU/g, with specific absence of pathogens including Escherichia coli and Salmonella.


Batch Consistency: Commercial production runs undergo multi-parameter testing across physical, chemical, and microbiological attributes prior to release.

 

Regulatory & Technical Documentation Support

 

Comprehensive Dossier Availability: Complete technical documentation packages provided to support customer regulatory submissions, customer technical reviews, and facility audits.


Core Analytical Certificates: Certificates of Analysis supplied for registration, pilot, and commercial validation batches, reflecting verified multi-parameter testing.


Safety & Regulatory Declarations: Material Safety Data Sheets fully compliant with current GHS standards, alongside BSE/TSE-Free certificates, non-GMO declarations, and allergen statements.


Core Technical Specifications: Detailed Product Specifications, Method of Analysis, and validated Route of Synthesis descriptions available upon formal request.


DMF & CEP Support: Full coordination for active Drug Master Files and Certificates of Suitability aligned with major regulatory bodies including US FDA, European EMA, and Japanese PMDA.

 

Storage Guidelines

 

Temperature Control: Store between 15 deg C and 25 deg C with excursions permitted up to 30 deg C under warehouse conditions.


Light Protection: Store in light-resistant containers to prevent photochemical degradation caused by prolonged ultraviolet exposure.


Moisture Defense: Keep containers tightly sealed with high-density polyethylene liners and active desiccant canisters inside the drum.

 

Packaging & Logistics

 

Primary Packaging: Double-layered food-grade low-density polyethylene bags heat-sealed under nitrogen purge to eliminate residual oxygen.


Secondary Packaging: Rigid fiber drums providing mechanical protection and tamper-evident sealing during transit.


Transport Conditions: Shipped via temperature-monitored freight carriers under ambient conditions, accompanied by dangerous goods documentation.

 

Frequently Asked Questions

 

Q: What is the standard commercial batch size available?

A: Standard commercial production runs are supplied in 25 kg net weight fiber drums, with smaller configurations available for R&D evaluation lots.

Q: Does the material comply with pharmacopeial monographs?

A: Synthesis and analytical testing follow current pharmacopeial monographs, with release testing tailored to regional requirements upon agreement.

Q: How is the residual solvent profile managed during synthesis?

A: Only Class 3 solvents are employed in final crystallization and purification steps, verified and reported on every batch certificate of analysis.

Q: What is the established retest period for this product?

A: The retest period is 24 months from the manufacture date when stored in original unopened containers under recommended conditions.

Hot Tags: vardenafil hydrochloride, China vardenafil hydrochloride manufacturers, suppliers, factory, CAS 171599 83 0, CAS 18850 57 5, Dapoxetine HCl powder, Jinyang Base Powder CAS 18850 57 5, sildenafil crystalline powder, testosterone enanthate analytical standard

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag